| Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition SY Sun, LM Rosenberg, X Wang, Z Zhou, P Yue, H Fu, FR Khuri Cancer research 65 (16), 7052-7058, 2005 | 945 | 2005 |
| Apoptosis as a novel target for cancer chemoprevention SY Sun, N Hail Jr, R Lotan Journal of the national cancer institute 96 (9), 662-672, 2004 | 670 | 2004 |
| Retinoids and their receptors in cancer development and chemoprevention SY Sun, R Lotan Critical reviews in oncology/hematology 41 (1), 41-55, 2002 | 435 | 2002 |
| N-acetylcysteine, reactive oxygen species and beyond SY Sun Cancer biology & therapy 9 (2), 109-110, 2010 | 315 | 2010 |
| Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells X Liu, P Yue, Z Zhou, FR Khuri, SY Sun Journal of the National Cancer Institute 96 (23), 1769-1780, 2004 | 297 | 2004 |
| Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells SY Sun, P Yue, MI Dawson, B Shroot, S Michel, WW Lamph, RA Heyman, ... Cancer Research 57 (21), 4931-4939, 1997 | 251 | 1997 |
| p53 upregulates death receptor 4 expression through an intronic p53 binding site X Liu, P Yue, FR Khuri, SY Sun Cancer research 64 (15), 5078-5083, 2004 | 243 | 2004 |
| MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer Q Wang, S Yang, K Wang, SY Sun Journal of hematology & oncology 12, 1-11, 2019 | 210 | 2019 |
| c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano … W Zou, X Liu, P Yue, Z Zhou, MB Sporn, R Lotan, FR Khuri, SY Sun Cancer research 64 (20), 7570-7578, 2004 | 197 | 2004 |
| Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation X Wang, P Yue, CB Chan, K Ye, T Ueda, R Watanabe-Fukunaga, ... Molecular and cellular biology 27 (21), 7405-7413, 2007 | 194 | 2007 |
| The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c … X Liu, P Yue, S Chen, L Hu, S Lonial, FR Khuri, SY Sun Cancer research 67 (10), 4981-4988, 2007 | 189 | 2007 |
| Inhibition of IκB kinase-nuclear factor-κB signaling pathway by 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), a novel monoketone analog of curcumin AL Kasinski, Y Du, SL Thomas, J Zhao, SY Sun, FR Khuri, CY Wang, ... Molecular pharmacology 74 (3), 654-661, 2008 | 182 | 2008 |
| Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy L Fu, YA Kim, X Wang, X Wu, P Yue, S Lonial, FR Khuri, SY Sun Cancer research 69 (23), 8967-8976, 2009 | 181 | 2009 |
| Mediation of N-(4-hydoxyphenyl) retinamide-induced apoptosis in human cancer cells by different mechanisms SY Sun, W Li, P Yue, SM Lippman, WK Hong, R Lotan Cancer Research 59 (10), 2493-2498, 1999 | 180 | 1999 |
| p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells S Kang, S Elf, K Lythgoe, T Hitosugi, J Taunton, W Zhou, L Xiong, D Wang, ... The Journal of clinical investigation 120 (4), 1165-1177, 2010 | 179 | 2010 |
| Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation Z Li, J Zhao, Y Du, HR Park, SY Sun, L Bernal-Mizrachi, A Aitken, ... Proceedings of the National Academy of Sciences 105 (1), 162-167, 2008 | 179 | 2008 |
| Enhancing mammalian target of rapamycin (mTOR)–targeted cancer therapy by preventing mTOR/Raptor inhibition-initiated, mTOR/Rictor-independent Akt activation X Wang, P Yue, YA Kim, H Fu, FR Khuri, SY Sun Cancer research 68 (18), 7409-7418, 2008 | 177 | 2008 |
| Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non–small cell lung cancer R Li, Z Hu, SY Sun, ZG Chen, TK Owonikoko, GL Sica, SS Ramalingam, ... Molecular cancer therapeutics 12 (10), 2200-2212, 2013 | 176 | 2013 |
| Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model X Zhang, Z Chen, MS Choe, Y Lin, SY Sun, HS Wieand, HJC Shin, ... Clinical Cancer Research 11 (17), 6261-6269, 2005 | 175 | 2005 |
| Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells SY Sun, P Yue, JY Zhou, Y Wang, HRC Kim, R Lotan, GS Wu Biochemical and biophysical research communications 280 (3), 788-797, 2001 | 175 | 2001 |
